Literature DB >> 23218226

Seasonality of Yersinia enterocolitica bioserotype 1B/O:8 infections in Poland.

W Rastawicki1, J Szych, N Rokosz, K Zacharczuk, R Gierczyński.   

Abstract

Both serological and bacteriological investigations revealed a cyclic, seasonal pattern of Yersinia enterocolitica 1B/O8 infections in Poland during the years 2008–2011. A large increase in incidence was observed in the second quarter and a decrease in the third quarter of each year. Such seasonal changes were not seen in the case of infections caused by the other enteropathogenic Yersinia bioserotypes.

Entities:  

Mesh:

Year:  2012        PMID: 23218226      PMCID: PMC9151429          DOI: 10.1017/S0950268812002786

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  21 in total

1.  Yersinia enterocolitica strains associated with human infections in Switzerland 2001-2010.

Authors:  M Fredriksson-Ahomaa; N Cernela; H Hächler; R Stephan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-10       Impact factor: 3.267

2.  Yersinia enterocolitica O:3 antibodies in slaughterhouse employees, veterinarians, and military recruits. Occupational exposure to pigs as a risk factor for yersiniosis.

Authors:  T Nesbakken; G Kapperud; J Lassen; E Skjerve
Journal:  Contrib Microbiol Immunol       Date:  1991

3.  A dramatic increase of Yersinia enterocolitica serogroup O:8 infections in Poland.

Authors:  W Rastawicki; J Szych; R Gierczyński; N Rokosz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-24       Impact factor: 3.267

4.  A simplified antigenic scheme for serotyping of Yersinia pseudotuberculosis: phenotypic characterization of reference strains and preparation of O and H factor sera.

Authors:  M Tsubokura; S Aleksić
Journal:  Contrib Microbiol Immunol       Date:  1995

5.  Sources of sporadic human infection with Yersinia enterocolitica serovar O:8 in Aomori Prefecture, Japan.

Authors:  H Hayashidani; Y Ohtomo; Y Toyokawa; M Saito; K Kaneko; J Kosuge; M Kato; M Ogawa; G Kapperud
Journal:  Contrib Microbiol Immunol       Date:  1995

6.  Yersinia enterocolitica 08 "American strain" isolated in Italy.

Authors:  A Martini; M Fantasia; A Raballo
Journal:  Microbiologica       Date:  1989-10

7.  Detection of pathogenic Yersinia enterocolitica by using congo red-magnesium oxalate agar medium.

Authors:  G Riley; S Toma
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

8.  [Evaluation of the usefulness of the latex test for detection and identification of O-antigens of Yersinia enterocolitica and Yersinia pseudotuberculosis].

Authors:  M Jagielski; M Kochman; J Szych; S Kałuzewski; W Rastawicki
Journal:  Med Dosw Mikrobiol       Date:  1996

9.  Yersinia enterocolitica serovar O:8 infection in breeding monkeys in Japan.

Authors:  Taketoshi Iwata; Yumi Une; Alexandre Tomomitsu Okatani; Sei-Ichi Kaneko; Satoshi Namai; Shin-Ichiro Yoshida; Tomoko Horisaka; Tetsuya Horikita; Aya Nakadai; Hideki Hayashidani
Journal:  Microbiol Immunol       Date:  2005       Impact factor: 1.955

10.  Immunochemical analysis of plasmid-encoded proteins released by enteropathogenic Yersinia sp. grown in calcium-deficient media.

Authors:  J Heesemann; U Gross; N Schmidt; R Laufs
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

View more
  2 in total

1.  The prevalence of Yersinia enterocolitica in game animals in Poland.

Authors:  Kinga Syczyło; Aleksandra Platt-Samoraj; Agata Bancerz-Kisiel; Anna Szczerba-Turek; Joanna Pajdak-Czaus; Sebastian Łabuć; Zbigniew Procajło; Piotr Socha; Gulzhan Chuzhebayeva; Wojciech Szweda
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

2.  Isolation of a Yersinia enterocolitica biotype 1B strain in France, and evaluation of its genetic relatedness to other European and North American biotype 1B strains.

Authors:  Cyril Savin; Anne-Sophie Le Guern; Matthieu Lefranc; Sylvie Brémont; Elisabeth Carniel; Javier Pizarro-Cerdá
Journal:  Emerg Microbes Infect       Date:  2018-07-04       Impact factor: 7.163

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.